Skip to main content
Erschienen in: Head and Neck Pathology 3/2022

29.03.2022 | Original Paper

Expression of a Tumor Stem Cell Marker (Aldehyde Dehydrogenase 1-ALDH1) in Benign Epithelial Odontogenic Lesions

verfasst von: Gustavo Alcântara da Trindade, Leorik Pereira da Silva, Pedro Paulo de Andrade Santos, Leão Pereira Pinto, Lélia Batista de Souza

Erschienen in: Head and Neck Pathology | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

The morphological diversity and different biological behaviors of human lesions has been attributed to the presence of cells with stem cell (SC) characteristics. Among SC markers, ALDH1 has been used in studies investigating different neoplasms and high expression of this marker was associated with clinicopathological features and prognosis in some groups. The aim of this study was to analyze the presence and distribution of SCs based on the expression of ALDH1 in epithelial odontogenic cysts and tumors. The sample consisted of 80 cases (20 dentigerous cysts (DCs), 20 odontogenic keratocysts (OKCs), 20 ameloblastomas (AMs), and 20 adenomatoid odontogenic tumors (AOTs). An immunoreactivity score was obtained from the percentage of positive cells and intensity of immunostaining. A level of 5% (p < 0.05) was adopted for the statistical tests. Immunoexpression of ALDH1 was observed in cytoplasm and nucleus-cytoplasm. The median scores indicated significantly higher expression in OKCs and DCs compared to AMs (p < 0.0001) and AOTs (p < 0.0001). In the tumor stroma and cystic capsule, immunoreactivity was detected in all odontogenic cysts studied and in 85% and 90% of AMs and AOTs, respectively. The expression of ALDH1 suggests the presence of SCs in the odontogenic lesions studied. Epithelial immunoexpression was higher in odontogenic cysts than in odontogenic tumors.
Literatur
1.
Zurück zum Zitat Wright JM, Vered M. Update from the 4th edition of the World Health Organization classification of head and neck tumours: odontogenic and maxillofacial bone tumors. Head Neck Pathol. 2017;11(1):68–77.CrossRef Wright JM, Vered M. Update from the 4th edition of the World Health Organization classification of head and neck tumours: odontogenic and maxillofacial bone tumors. Head Neck Pathol. 2017;11(1):68–77.CrossRef
2.
Zurück zum Zitat Soluk-Tekkeşin M, Wright JM. The World Health Organization classification of odontogenic lesions: a summary of the changes of the 2017 (4th) edition. Turk Patoloji Derg. 2018;34(1):1–18. Soluk-Tekkeşin M, Wright JM. The World Health Organization classification of odontogenic lesions: a summary of the changes of the 2017 (4th) edition. Turk Patoloji Derg. 2018;34(1):1–18.
3.
Zurück zum Zitat Jaeger F, de Noronha MS, Silva ML, Amaral MB, Grossmann SM, Horta MC, de Souza PE, de Aguiar MC, Mesquita RA. Prevalence profile of odontogenic cysts and tumors on Brazilian sample after the reclassification of odontogenic keratocyst. J Craniomaxillofac Surg. 2017;45(2):267–70.CrossRef Jaeger F, de Noronha MS, Silva ML, Amaral MB, Grossmann SM, Horta MC, de Souza PE, de Aguiar MC, Mesquita RA. Prevalence profile of odontogenic cysts and tumors on Brazilian sample after the reclassification of odontogenic keratocyst. J Craniomaxillofac Surg. 2017;45(2):267–70.CrossRef
4.
Zurück zum Zitat De Medeiros WK, da Silva LP, Santos PP, Pinto LP, de Souza LB. Clinicopathological analysis of odontogenic tumors over 22 years period: experience of a single center in northeastern Brazil. Med Oral Patol Oral Cir Bucal. 2018;23(6):e664–71.PubMedPubMedCentral De Medeiros WK, da Silva LP, Santos PP, Pinto LP, de Souza LB. Clinicopathological analysis of odontogenic tumors over 22 years period: experience of a single center in northeastern Brazil. Med Oral Patol Oral Cir Bucal. 2018;23(6):e664–71.PubMedPubMedCentral
5.
Zurück zum Zitat Harada H, Mitsuyasu T, Toyono T, Toyoshima K. Epithelial stem cells in teeth. Odontology. 2002;90(1):1–6.CrossRef Harada H, Mitsuyasu T, Toyono T, Toyoshima K. Epithelial stem cells in teeth. Odontology. 2002;90(1):1–6.CrossRef
6.
Zurück zum Zitat Juuri E, Isaksson S, Jussila M, Heikinheimo K, Thesleff I. Expression of the stem cell marker, SOX2, in ameloblastoma and dental epithelium. Eur J Oral Sci. 2013;121(6):509–16.CrossRef Juuri E, Isaksson S, Jussila M, Heikinheimo K, Thesleff I. Expression of the stem cell marker, SOX2, in ameloblastoma and dental epithelium. Eur J Oral Sci. 2013;121(6):509–16.CrossRef
7.
Zurück zum Zitat Lee SH, Oh SY, Do SI, Lee HJ, Kang HJ, Rho YS, Bae WJ, Lim YC. SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma. Br J Cancer. 2014;111(11):2122–30.CrossRef Lee SH, Oh SY, Do SI, Lee HJ, Kang HJ, Rho YS, Bae WJ, Lim YC. SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma. Br J Cancer. 2014;111(11):2122–30.CrossRef
8.
Zurück zum Zitat Zhou C, Sun B. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis. Oral Oncol. 2014;50(12):1144–8.CrossRef Zhou C, Sun B. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis. Oral Oncol. 2014;50(12):1144–8.CrossRef
9.
Zurück zum Zitat Wei D, Peng JJ, Gao H, Zhang T, Tan Y, Hu YH. ALDH1 expression and the prognosis of lung cancer: a systematic review and meta-analysis. Heart Lung Circ. 2015;24(8):780–8.CrossRef Wei D, Peng JJ, Gao H, Zhang T, Tan Y, Hu YH. ALDH1 expression and the prognosis of lung cancer: a systematic review and meta-analysis. Heart Lung Circ. 2015;24(8):780–8.CrossRef
10.
Zurück zum Zitat Curtarelli RB, Gonçalves JM, Dos Santos LGP, Savi MG, Nör JE, Mezzomo LAM, Rodríguez Cordeiro MM. Expression of cancer stem cell biomarkers in human head and neck carcinomas: a systematic review. Stem Cell Rev Rep. 2018;14(6):769–84.CrossRef Curtarelli RB, Gonçalves JM, Dos Santos LGP, Savi MG, Nör JE, Mezzomo LAM, Rodríguez Cordeiro MM. Expression of cancer stem cell biomarkers in human head and neck carcinomas: a systematic review. Stem Cell Rev Rep. 2018;14(6):769–84.CrossRef
11.
Zurück zum Zitat Monroy EAC, de Andrade Santos PP, de Sousa Lopes MLD, Mosqueda-Taylor A, Pinto LP, de Souza LB. Oct-4 and CD44 in epithelial stem cells like of benign odontogenic lesions. Histochem Cell Biol. 2018;150(4):371–7.CrossRef Monroy EAC, de Andrade Santos PP, de Sousa Lopes MLD, Mosqueda-Taylor A, Pinto LP, de Souza LB. Oct-4 and CD44 in epithelial stem cells like of benign odontogenic lesions. Histochem Cell Biol. 2018;150(4):371–7.CrossRef
12.
Zurück zum Zitat da Silva LP, Lopes MLDS, Sarmento ASC, de Albuquerque Borges M, de Moura SRS, Sobral APV, de Souza LB. Increased expression of ALDH-1 is associated with clinical parameters of salivary glands neoplasms. Exp Mol Pathol. 2020;117:104552.CrossRef da Silva LP, Lopes MLDS, Sarmento ASC, de Albuquerque Borges M, de Moura SRS, Sobral APV, de Souza LB. Increased expression of ALDH-1 is associated with clinical parameters of salivary glands neoplasms. Exp Mol Pathol. 2020;117:104552.CrossRef
13.
Zurück zum Zitat Kahraman D, Gunhan O, Celasun B. A series of 240 odontogenic keratocysts: should we continue to use the terminology of “keratocystic odontogenic tumour” for the solid variant of odontogenic keratocyst? J Craniomaxillofac Surg. 2018;46(6):942–6.CrossRef Kahraman D, Gunhan O, Celasun B. A series of 240 odontogenic keratocysts: should we continue to use the terminology of “keratocystic odontogenic tumour” for the solid variant of odontogenic keratocyst? J Craniomaxillofac Surg. 2018;46(6):942–6.CrossRef
14.
Zurück zum Zitat Padma Priya S, Higuchi A, Abu Fanas S, Pooi Ling M, Kumari Neela V, Sunil PM, Saraswathi TR, Murugan K, Alarfaj AA, Munusamy MA, Kumar S. Odontogenic epithelial stem cells: hidden sources. Lab Invest. 2015;95(12):1344–52.CrossRef Padma Priya S, Higuchi A, Abu Fanas S, Pooi Ling M, Kumari Neela V, Sunil PM, Saraswathi TR, Murugan K, Alarfaj AA, Munusamy MA, Kumar S. Odontogenic epithelial stem cells: hidden sources. Lab Invest. 2015;95(12):1344–52.CrossRef
15.
Zurück zum Zitat Zhou JH, Hanna EY, Roberts D, Weber RS, Bell D. ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinoma. Head Neck. 2012;35(4):575–8.CrossRef Zhou JH, Hanna EY, Roberts D, Weber RS, Bell D. ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinoma. Head Neck. 2012;35(4):575–8.CrossRef
16.
Zurück zum Zitat Tomita H, Tanaka K, Tanaka T, Hara A. Aldehyde dehydrogenase 1A1 in stem cells and cancer. Oncotarget. 2016;7(10):11018–32.CrossRef Tomita H, Tanaka K, Tanaka T, Hara A. Aldehyde dehydrogenase 1A1 in stem cells and cancer. Oncotarget. 2016;7(10):11018–32.CrossRef
17.
Zurück zum Zitat Heikinheimo K, Kurppa KJ, Laiho A, Peltonen S, Berdal A, Bouattour A, Ruhin B, Catón J, Thesleff I, Leivo I, Morgan PR. Early dental epithelial transcription factors distinguish ameloblastoma from keratocystic odontogenic tumor. J Dent Res. 2015;94(1):101–11.CrossRef Heikinheimo K, Kurppa KJ, Laiho A, Peltonen S, Berdal A, Bouattour A, Ruhin B, Catón J, Thesleff I, Leivo I, Morgan PR. Early dental epithelial transcription factors distinguish ameloblastoma from keratocystic odontogenic tumor. J Dent Res. 2015;94(1):101–11.CrossRef
18.
Zurück zum Zitat de Oliveira MG, Lauxen Ida S, Chaves AC, Rados PV, Santana-Filho M. Immunohistochemical analysis of the patterns of p53 and PCNA expression in odontogenic cystic lesions. Med Oral Patol Oral Cir Bucal. 2008;13(5):E275–80.PubMed de Oliveira MG, Lauxen Ida S, Chaves AC, Rados PV, Santana-Filho M. Immunohistochemical analysis of the patterns of p53 and PCNA expression in odontogenic cystic lesions. Med Oral Patol Oral Cir Bucal. 2008;13(5):E275–80.PubMed
19.
Zurück zum Zitat da Silva LP, Serpa MS, Santana T, do Nascimento GJ, de Souza-Andrade ES, Sobral AP. Clinicopathological and cell proliferation evaluation of ameloblastomas and keratocystic odontogenic tumors: a 10 year retrospective study. Eur Arch Otorhinolaryngol. 2016;274(2):1089–95.CrossRef da Silva LP, Serpa MS, Santana T, do Nascimento GJ, de Souza-Andrade ES, Sobral AP. Clinicopathological and cell proliferation evaluation of ameloblastomas and keratocystic odontogenic tumors: a 10 year retrospective study. Eur Arch Otorhinolaryngol. 2016;274(2):1089–95.CrossRef
20.
Zurück zum Zitat Soluk Tekkeşın M, Mutlu S, Olgaç V. Expressions of bax, bcl-2 and Ki-67 in odontogenic keratocysts (Keratocystic Odontogenic Tumor) in comparison with ameloblastomas and radicular cysts. Turk Patoloji Derg. 2012;28(1):49–55.PubMed Soluk Tekkeşın M, Mutlu S, Olgaç V. Expressions of bax, bcl-2 and Ki-67 in odontogenic keratocysts (Keratocystic Odontogenic Tumor) in comparison with ameloblastomas and radicular cysts. Turk Patoloji Derg. 2012;28(1):49–55.PubMed
21.
Zurück zum Zitat Browne RM. Per[cyst]ent growth: the odontogenic keratocyst 40 years on. Ann R Coll Surg Engl. 1996;78(5):426–33.PubMedPubMedCentral Browne RM. Per[cyst]ent growth: the odontogenic keratocyst 40 years on. Ann R Coll Surg Engl. 1996;78(5):426–33.PubMedPubMedCentral
22.
Zurück zum Zitat Yajima-Himuro S, Oshima M, Yamamoto G, Ogawa M, Furuya M, Tanaka J, Nishii K, Mishima K, Tachikawa T, Tsuji T, Yamamoto M. The junctional epithelium originates from the odontogenic epithelium of an erupted tooth. Sci Rep. 2014;4:4867.CrossRef Yajima-Himuro S, Oshima M, Yamamoto G, Ogawa M, Furuya M, Tanaka J, Nishii K, Mishima K, Tachikawa T, Tsuji T, Yamamoto M. The junctional epithelium originates from the odontogenic epithelium of an erupted tooth. Sci Rep. 2014;4:4867.CrossRef
23.
Zurück zum Zitat Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M, Marini F. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS ONE. 2019;4(4):e4992.CrossRef Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M, Marini F. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS ONE. 2019;4(4):e4992.CrossRef
Metadaten
Titel
Expression of a Tumor Stem Cell Marker (Aldehyde Dehydrogenase 1-ALDH1) in Benign Epithelial Odontogenic Lesions
verfasst von
Gustavo Alcântara da Trindade
Leorik Pereira da Silva
Pedro Paulo de Andrade Santos
Leão Pereira Pinto
Lélia Batista de Souza
Publikationsdatum
29.03.2022
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 3/2022
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-022-01430-z

Weitere Artikel der Ausgabe 3/2022

Head and Neck Pathology 3/2022 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …